A Study to Evaluate Scales for Repetitive and Restricted Behaviors in Children, Adolescents, and Adults With Autism Spectrum Disorder (ASD)

PHASE1CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

August 13, 2018

Primary Completion Date

May 21, 2020

Study Completion Date

May 21, 2020

Conditions
Autism Spectrum Disorder
Interventions
OTHER

No Intervention

No interventions are administered in this study

Trial Locations (18)

10461

Albert Einstein College of Medicine, The Bronx

10962

Nathan S. Kline Institute for Psychiatric Research, Orangeburg

19104

Children's Hospital of Philadelphia, Philadelphia

32256

Clinical Neuroscience Solutions Inc; Jacksonville Clinic, Jacksonville

36303

Harmonex Neuroscience Research, Dothan

44106

University Hospitals Case Medical Center, Cleveland

55414

University of Minnesota; Clin. Neuro Research Unit, Minneapolis

77090

Red Oak Psychiatry Associates, PA, Houston

78258

Road Runner Research Ltd, San Antonio

78759

BioBehavioral Research of Austin, PC, Austin

85006

Southwest Autism Research and Resource Center, Phoenix

92108

PCSD Feighner Research, San Diego

94305

Stanford University School of Medicine, Stanford

98007

Northwest Clinical Research Center - ClinEdge - PPDS, Bellevue

98105

Seattle Children's Hospital - PIN; Investigational Drug Services, Seattle

M4G 1R8

Holland Bloorview Kids Rehabilitation Hospital; Autism Research Centre, East York

G12 0XH

Gartnavel Royal Hospital; Mental Health & Wellbeing, Glasgow

WC2R 2LS

Kings College London, London

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT03611075 - A Study to Evaluate Scales for Repetitive and Restricted Behaviors in Children, Adolescents, and Adults With Autism Spectrum Disorder (ASD) | Biotech Hunter | Biotech Hunter